IBDEI0U4 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13409,1,3,0)
 ;;=3^Rash/Other Nonspec Skin Eruption
 ;;^UTILITY(U,$J,358.3,13409,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,13409,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,13410,0)
 ;;=L71.9^^83^810^93
 ;;^UTILITY(U,$J,358.3,13410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13410,1,3,0)
 ;;=3^Rosacea,Unspec
 ;;^UTILITY(U,$J,358.3,13410,1,4,0)
 ;;=4^L71.9
 ;;^UTILITY(U,$J,358.3,13410,2)
 ;;=^5009276
 ;;^UTILITY(U,$J,358.3,13411,0)
 ;;=L82.0^^83^810^94
 ;;^UTILITY(U,$J,358.3,13411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13411,1,3,0)
 ;;=3^Seborrheic Keratosis,Inflamed
 ;;^UTILITY(U,$J,358.3,13411,1,4,0)
 ;;=4^L82.0
 ;;^UTILITY(U,$J,358.3,13411,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,13412,0)
 ;;=L82.1^^83^810^95
 ;;^UTILITY(U,$J,358.3,13412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13412,1,3,0)
 ;;=3^Seborrheic Keratosis,Other
 ;;^UTILITY(U,$J,358.3,13412,1,4,0)
 ;;=4^L82.1
 ;;^UTILITY(U,$J,358.3,13412,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,13413,0)
 ;;=L92.9^^83^810^42
 ;;^UTILITY(U,$J,358.3,13413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13413,1,3,0)
 ;;=3^Granulomatous Disorder of Skin,Unspec
 ;;^UTILITY(U,$J,358.3,13413,1,4,0)
 ;;=4^L92.9
 ;;^UTILITY(U,$J,358.3,13413,2)
 ;;=^5009466
 ;;^UTILITY(U,$J,358.3,13414,0)
 ;;=L98.9^^83^810^101
 ;;^UTILITY(U,$J,358.3,13414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13414,1,3,0)
 ;;=3^Skin Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,13414,1,4,0)
 ;;=4^L98.9
 ;;^UTILITY(U,$J,358.3,13414,2)
 ;;=^5009595
 ;;^UTILITY(U,$J,358.3,13415,0)
 ;;=L08.9^^83^810^104
 ;;^UTILITY(U,$J,358.3,13415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13415,1,3,0)
 ;;=3^Skin Infection,Local,Unspec
 ;;^UTILITY(U,$J,358.3,13415,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,13415,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,13416,0)
 ;;=L57.9^^83^810^97
 ;;^UTILITY(U,$J,358.3,13416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13416,1,3,0)
 ;;=3^Skin Changes d/t Chr Expsr to Nonionizing Radiation,Unspec
 ;;^UTILITY(U,$J,358.3,13416,1,4,0)
 ;;=4^L57.9
 ;;^UTILITY(U,$J,358.3,13416,2)
 ;;=^5009227
 ;;^UTILITY(U,$J,358.3,13417,0)
 ;;=L90.9^^83^810^99
 ;;^UTILITY(U,$J,358.3,13417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13417,1,3,0)
 ;;=3^Skin Disorder,Atrophic,Unspec
 ;;^UTILITY(U,$J,358.3,13417,1,4,0)
 ;;=4^L90.9
 ;;^UTILITY(U,$J,358.3,13417,2)
 ;;=^5009458
 ;;^UTILITY(U,$J,358.3,13418,0)
 ;;=L91.9^^83^810^100
 ;;^UTILITY(U,$J,358.3,13418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13418,1,3,0)
 ;;=3^Skin Disorder,Hypertrophic,Unspec
 ;;^UTILITY(U,$J,358.3,13418,1,4,0)
 ;;=4^L91.9
 ;;^UTILITY(U,$J,358.3,13418,2)
 ;;=^5009461
 ;;^UTILITY(U,$J,358.3,13419,0)
 ;;=R20.0^^83^810^96
 ;;^UTILITY(U,$J,358.3,13419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13419,1,3,0)
 ;;=3^Skin Anesthesia
 ;;^UTILITY(U,$J,358.3,13419,1,4,0)
 ;;=4^R20.0
 ;;^UTILITY(U,$J,358.3,13419,2)
 ;;=^5019278
 ;;^UTILITY(U,$J,358.3,13420,0)
 ;;=R20.3^^83^810^102
 ;;^UTILITY(U,$J,358.3,13420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13420,1,3,0)
 ;;=3^Skin Hyperesthesia
 ;;^UTILITY(U,$J,358.3,13420,1,4,0)
 ;;=4^R20.3
 ;;^UTILITY(U,$J,358.3,13420,2)
 ;;=^60011
 ;;^UTILITY(U,$J,358.3,13421,0)
 ;;=R20.1^^83^810^103
 ;;^UTILITY(U,$J,358.3,13421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13421,1,3,0)
 ;;=3^Skin Hypoesthesia
 ;;^UTILITY(U,$J,358.3,13421,1,4,0)
 ;;=4^R20.1
 ;;^UTILITY(U,$J,358.3,13421,2)
 ;;=^5019279
